Literature DB >> 12530765

Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database.

J B Soriano1, W C Maier, G Visick, N B Pride.   

Abstract

BACKGROUND: Information in large, automated databases can be useful to study the natural history of respiratory diseases in the community, but the validity of definitions needs to be demonstrated. AIM: To compare a simple computer algorithm that identifies patients diagnosed with chronic obstructive pulmonary disease (COPD) and severity of COPD in the UK General Practice Research Database (GPRD) with general practitioner (GP) clinical records, to evaluate the utility of this algorithm for identifying COPD patients and for distinguishing COPD from asthma.
METHODS: Using a computer algorithm identifying patients by diagnostic codes and allotting three grades of severity by drug use, a sample of 225 patients in the GPRD with a diagnosis of COPD and an age-sex matched group of 75 patients with asthma were randomly selected. Questionnaires were posted to the GPs of the 300 selected patients who were asked to state diagnosis and to grade severity based on the individual's medical record. Agreement was quantified with the kappa index, an estimator that accounts for agreement that occurs by chance.
RESULTS: Response rate was 85.7%. The concordance between COPD diagnosis by the GPRD algorithm with that of the GP was quantified as a kappa of 0.52, and the concordance between COPD severity by the GPRD algorithm with that of the GP was quantified as a kappa of 0.54. The kappa index for COPD diagnosis increased with increasing severity of COPD (0.46, 0.59, and 0.68 for mild, moderate and severe COPD, respectively), but similar good agreement was observed in a stratified analysis by sex, age, smoking status and number of comorbidities.
CONCLUSIONS: It is concluded that the GPRD algorithms used for diagnosis and severity of COPD are a good screening tool for COPD in the UK general population, and satisfactorily differentiate COPD from asthma patients, particularly when disease is moderate or severe.

Entities:  

Mesh:

Year:  2001        PMID: 12530765     DOI: 10.1023/a:1021235123382

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  16 in total

Review 1.  Asthma versus chronic obstructive pulmonary disease--exploring why 'reversibility versus irreversibility' is no longer an appropriate approach.

Authors:  L Dow
Journal:  Clin Exp Allergy       Date:  1999-06       Impact factor: 5.018

2.  Feasibility of spirometry and reversibility testing for the identification of patients with chronic obstructive pulmonary disease on asthma registers in general practice.

Authors:  C Griffiths; G Feder; J Wedzicha; G Foster; A Livingstone; G S Marlowe
Journal:  Respir Med       Date:  1999-12       Impact factor: 3.415

3.  Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.

Authors:  H Jick; S S Jick; L E Derby
Journal:  BMJ       Date:  1991-03-30

4.  Use of the UK General Practice Research Database for pharmacoepidemiology.

Authors:  L A García Rodríguez; S Pérez Gutthann
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  Recent trends in physician diagnosed COPD in women and men in the UK.

Authors:  J B Soriano; W C Maier; P Egger; G Visick; B Thakrar; J Sykes; N B Pride
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

7.  Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care.

Authors:  C O'Brien; P J Guest; S L Hill; R A Stockley
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

8.  Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study.

Authors:  G A Traver; M G Cline; B Burrows
Journal:  Am Rev Respir Dis       Date:  1979-06

9.  Reliability of a monitoring system for respiratory emergency room admissions.

Authors:  F Martínez; J Sunyer; J M Antó
Journal:  Eur Respir J       Date:  1993-03       Impact factor: 16.671

10.  Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles.

Authors:  N S Rawson; E Malcolm
Journal:  Stat Med       Date:  1995-12-30       Impact factor: 2.373

View more
  26 in total

1.  Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease?

Authors:  L J Tata; J West; T Harrison; P Farrington; C Smith; R Hubbard
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

2.  Regional variation in medical classification agreement: benchmarking the coding gap.

Authors:  Daniel Lorence
Journal:  J Med Syst       Date:  2003-10       Impact factor: 4.460

Review 3.  Validity of diagnostic coding within the General Practice Research Database: a systematic review.

Authors:  Nada F Khan; Sian E Harrison; Peter W Rose
Journal:  Br J Gen Pract       Date:  2010-03       Impact factor: 5.386

Review 4.  A pathway to improved prospective observational post-authorization safety studies.

Authors:  Victor A Kiri
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

5.  Validating the 8 CPCSSN case definitions for chronic disease surveillance in a primary care database of electronic health records.

Authors:  Tyler Williamson; Michael E Green; Richard Birtwhistle; Shahriar Khan; Stephanie Garies; Sabrina T Wong; Nandini Natarajan; Donna Manca; Neil Drummond
Journal:  Ann Fam Med       Date:  2014-07       Impact factor: 5.166

6.  Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database.

Authors:  Ameet Sarpatwari; Dimitri Bennett; John W Logie; Amit Shukla; Kathleen J Beach; Adrian C Newland; Simon Sanderson; Drew Provan
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

7.  Chronic obstructive pulmonary disease and the risk of cardiovascular diseases.

Authors:  Cornelia Schneider; Ulrich Bothner; Susan S Jick; Christoph R Meier
Journal:  Eur J Epidemiol       Date:  2010-02-27       Impact factor: 8.082

8.  Chronic obstructive pulmonary disease severity and cardiovascular outcomes.

Authors:  Suellen M Curkendall; Stephan Lanes; Cynthia de Luise; Mary Rose Stang; Judith K Jones; Dewei She; Earl Goehring
Journal:  Eur J Epidemiol       Date:  2006-11-15       Impact factor: 8.082

9.  The sex factor: epidemiology and management of chronic obstructive pulmonary disease in British Columbia.

Authors:  Pat G Camp; Munaza Chaudhry; Howard Platt; Michael Roch; Jeremy Road; Donald Sin; Robert D Levy
Journal:  Can Respir J       Date:  2008 Nov-Dec       Impact factor: 2.409

Review 10.  Validation and validity of diagnoses in the General Practice Research Database: a systematic review.

Authors:  Emily Herrett; Sara L Thomas; W Marieke Schoonen; Liam Smeeth; Andrew J Hall
Journal:  Br J Clin Pharmacol       Date:  2010-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.